Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

Public health and economic benefits of new pediatric influenza vaccination programs in Argentina.

Giglio N, Gentile A, Lees L, Micone P, Armoni J, Reygrobellet C, Crépey P.

Hum Vaccin Immunother. 2012 Mar;8(3):312-22. doi: 10.4161/hv.18569. Epub 2012 Feb 14.

2.

Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.

Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dunham KM, Meltzer MI.

PLoS One. 2011;6(7):e22308. doi: 10.1371/journal.pone.0022308. Epub 2011 Jul 29.

3.

Cost-effectiveness of influenza vaccination in high-risk children in Argentina.

Dayan GH, Nguyen VH, Debbag R, Gómez R, Wood SC.

Vaccine. 2001 Jul 20;19(30):4204-13.

PMID:
11457546
4.

Cost-effectiveness of influenza vaccination of healthy children.

Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T.

Vaccine. 2006 Jun 5;24(23):4934-41. Epub 2006 Apr 7.

PMID:
16678945
5.

Health and economic impact of the seasonal influenza vaccination programme in England.

Baguelin M, Jit M, Miller E, Edmunds WJ.

Vaccine. 2012 May 14;30(23):3459-62. doi: 10.1016/j.vaccine.2012.03.019. Epub 2012 Mar 22.

PMID:
22446636
6.

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.

Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ.

Vaccine. 2010 Mar 11;28(12):2370-84. doi: 10.1016/j.vaccine.2010.01.002. Epub 2010 Jan 21.

PMID:
20096762
7.

Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model.

Pitman RJ, Nagy LD, Sculpher MJ.

Vaccine. 2013 Jan 30;31(6):927-42. doi: 10.1016/j.vaccine.2012.12.010. Epub 2012 Dec 14.

8.

Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.

Baguelin M, Camacho A, Flasche S, Edmunds WJ.

BMC Med. 2015 Oct 13;13:236. doi: 10.1186/s12916-015-0452-y.

9.

Cost-effectiveness study on influenza prevention in Hong Kong.

Fitzner KA, Shortridge KF, McGhee SM, Hedley AJ.

Health Policy. 2001 Jun;56(3):215-34.

PMID:
11399347
10.

Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.

Lugnér AK, van Boven M, de Vries R, Postma MJ, Wallinga J.

BMJ. 2012 Jul 12;345:e4445. doi: 10.1136/bmj.e4445.

11.

Influenza epidemiology in Italy two years after the 2009-2010 pandemic: need to improve vaccination coverage.

Gasparini R, Bonanni P, Amicizia D, Bella A, Donatelli I, Cristina ML, Panatto D, Lai PL.

Hum Vaccin Immunother. 2013 Mar;9(3):561-7. Epub 2013 Jan 4.

12.

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

Ryan J, Zoellner Y, Gradl B, Palache B, Medema J.

Vaccine. 2006 Nov 17;24(47-48):6812-22. Epub 2006 Aug 4.

PMID:
17034909
13.

An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.

Ng S, Wu P, Nishiura H, Ip DK, Lee ES, Cowling BJ.

BMC Infect Dis. 2011 Aug 26;11:230. doi: 10.1186/1471-2334-11-230.

14.

School-based influenza vaccine delivery, vaccination rates, and healthcare use in the context of a universal influenza immunization program: an ecological study.

Kwong JC, Ge H, Rosella LC, Guan J, Maaten S, Moran K, Johansen H, Guttmann A.

Vaccine. 2010 Mar 24;28(15):2722-9. doi: 10.1016/j.vaccine.2010.01.024. Epub 2010 Jan 26.

PMID:
20109594
15.

Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.

Brogan AJ, Talbird SE, Davis AE, Thommes EW, Meier G.

Hum Vaccin Immunother. 2017 Mar 4;13(3):533-542. doi: 10.1080/21645515.2016.1242541. Epub 2016 Oct 26.

16.

Influenza vaccination in kids, are you kidding me?

Ahout I, Ferwerda G, de Groot R.

J Infect. 2014 Jan;68 Suppl 1:S100-7. doi: 10.1016/j.jinf.2013.09.019. Epub 2013 Oct 25. Review.

PMID:
24206897
17.

Economic evaluation of the vaccination program against seasonal and pandemic A/H1N1 influenza among customs officers in Greece.

Mamma M, Spandidos DA.

Health Policy. 2013 Jan;109(1):71-7. doi: 10.1016/j.healthpol.2012.10.013. Epub 2012 Nov 26.

PMID:
23195436
18.

Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.

Yang MC, Tan EC, Su JJ.

Hum Vaccin Immunother. 2017 Jan 2;13(1):81-89. doi: 10.1080/21645515.2016.1225636. Epub 2016 Sep 13.

19.

Economic evaluations of childhood influenza vaccination: a critical review.

Newall AT, Jit M, Beutels P.

Pharmacoeconomics. 2012 Aug 1;30(8):647-60. doi: 10.2165/11599130-000000000-00000. Review.

PMID:
22788257
20.

Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.

Thommes EW, Ismaila A, Chit A, Meier G, Bauch CT.

BMC Infect Dis. 2015 Oct 27;15:465. doi: 10.1186/s12879-015-1193-4.

Supplemental Content

Support Center